» Articles » PMID: 22103353

Rectal Single Dose Immunization of Mice with Escherichia Coli O157:H7 Bacterial Ghosts Induces Efficient Humoral and Cellular Immune Responses and Protects Against the Lethal Heterologous Challenge

Overview
Date 2011 Nov 23
PMID 22103353
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Bacterial ghosts (BGs) have been applied through oral, aerogenic, intraocular or intranasal routes for mucosal immunization using a wide range of experimental animals. All these applications required a booster after primary immunization to achieve protective immunity against the lethal challenge. Here we report for the first time that a single rectal dose of BGs produced from enterohaemorrhagic Escherichia coli (EHEC) O157:H7 fully protects mice against a 50% lethal challenge with a heterologous EHEC strain given at day 55. BGs from EHEC O157:H7 were prepared by a combination of protein E-mediated cell lysis and expression of staphylococcal nuclease A guaranteeing the complete degradation of pathogen residual DNA. The lack of genetic material in the EHEC BGs vaccine abolished any potential hazard for horizontal gene transfer of plasmid encoded antibiotic resistance genes or pathogenic islands to the recipient's gut flora. Single rectal immunization using EHEC O157:H7 BGs without any addition of adjuvant significantly stimulated efficient humoral and cellular immune responses, and was equally protective as two immunizations, which indicates the possibility to develop a novel efficacious single dose mucosal EHEC O157:H7 BGs vaccine using a simplified immunization regimen.

Citing Articles

Delivery of a Hepatitis C Virus Vaccine Encoding NS3 Linked to the MHC Class II Chaperone Protein Invariant Chain Using Bacterial Ghosts.

Chi Y, Zhang S, Ji S Biomedicines. 2024; 12(3).

PMID: 38540137 PMC: 10968128. DOI: 10.3390/biomedicines12030525.


Cooperation between physiological defenses and immune resistance produces asymptomatic carriage of a lethal bacterial pathogen.

Chen G, Thorup N, Miller A, Li Y, Ayres J Sci Adv. 2023; 9(25):eadg8719.

PMID: 37352357 PMC: 10289649. DOI: 10.1126/sciadv.adg8719.


The Diversity of Pathotypes and Vaccination Strategies against This Versatile Bacterial Pathogen.

Pokharel P, Dhakal S, Dozois C Microorganisms. 2023; 11(2).

PMID: 36838308 PMC: 9965155. DOI: 10.3390/microorganisms11020344.


Cooperation between physiological defenses and immune resistance produces asymptomatic carriage of a lethal bacterial pathogen.

Chen G, Thorup N, Miller A, Li Y, Ayres J bioRxiv. 2023; .

PMID: 36711884 PMC: 9882269. DOI: 10.1101/2023.01.22.525099.


Diagnosis and Treatment for Shiga Toxin-Producing Associated Hemolytic Uremic Syndrome.

Liu Y, Thaker H, Wang C, Xu Z, Dong M Toxins (Basel). 2023; 15(1).

PMID: 36668830 PMC: 9862836. DOI: 10.3390/toxins15010010.


References
1.
Locking M, OBrien S, Reilly W, Wright E, Campbell D, Coia J . Risk factors for sporadic cases of Escherichia coli O157 infection: the importance of contact with animal excreta. Epidemiol Infect. 2001; 127(2):215-20. PMC: 2869740. DOI: 10.1017/s0950268801006045. View

2.
ORSKOV F, ORSKOV I, Villar J . Cattle as reservoir of verotoxin-producing Escherichia coli O157:H7. Lancet. 1987; 2(8553):276. DOI: 10.1016/s0140-6736(87)90860-9. View

3.
Witte A, Wanner G, Sulzner M, Lubitz W . Dynamics of PhiX174 protein E-mediated lysis of Escherichia coli. Arch Microbiol. 1992; 157(4):381-8. DOI: 10.1007/BF00248685. View

4.
Walcher P, Mayr U, Azimpour-Tabrizi C, Eko F, Jechlinger W, Mayrhofer P . Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors. Expert Rev Vaccines. 2004; 3(6):681-91. DOI: 10.1586/14760584.3.6.681. View

5.
Riedmann E, Kyd J, Cripps A, Lubitz W . Bacterial ghosts as adjuvant particles. Expert Rev Vaccines. 2007; 6(2):241-53. DOI: 10.1586/14760584.6.2.241. View